Clinical trials show stem cell therapies for Parkinson's disease are safe, potentially offering more effective treatment with ...

In a groundbreaking Phase I/II trial conducted at Kyoto University Hospital, researchers have demonstrated the potential of iPS-cell-derived dopaminergic progenitors in treating Parkinson’s disease.

Studies have also shown that sweeteners can stimulate the same neurons as the appetite hormone, leptin. Over time, this could ...

The researchers believe that the stem-cell treatment indeed holds the key to stopping Parkinson's Disease in its tracks, a ...

Stem cell therapies are a safe and effective way of treating Parkinson's disease, according to results of two independent ...

Two early-phase clinical trials demonstrate the safety and potential clinical utility of stem cell therapies to ease motor ...

The independent studies, conducted by research teams in Japan and the United States, demonstrate that stem cell-derived ...

Focal cortical dysplasia (FCD) type 2 is a congenital malformation of the cerebral cortex that is often associated with ...

Two pioneering clinical trials published in Nature have offered fresh hope for millions battling Parkinson’s disease, affirming that stem cell therapy is both safe and effective in treating the ...

Focal cortical dysplasia (FCD) type 2 is a congenital malformation of the cerebral cortex that is often associated with difficult-to-treat epilepsy. In the affected areas, nerve cells and their layer ...

Researchers have developed a treatment for Parkinson’s disease that involves creating nerve cells from embryonic stem cells ...